GlassScriptPhysician profile
William C Sloan
NPI 1578750204
$2,296.52
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,074 · 2020: $606 · 2021: $411 · 2022: $206.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $748.51 | 2019-2021 | |
| Gilead Sciences, INC. | $265.96 | 2019-2021 | |
| Pfizer INC. | $222.83 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $194.47 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $188.66 | 2021-2022 | |
| Abbvie INC. | $157.52 | 2019-2020 | |
| Janssen Biotech, INC. | $155.64 | 2019-2021 | |
| Daiichi Sankyo INC. | $94.57 | 2019-2021 | |
| Intercept Pharmaceuticals, INC. | $68.51 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $39.60 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.34 | 2019 | |
| Becton, Dickinson and Company | $30.65 | 2022 | |
| Ferring Pharmaceuticals INC. | $27.81 | 2019 | |
| Nestle Healthcare Nutrition INC. | $22.44 | 2020 | |
| Vivus LLC | $15.42 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $13.26 | 2021 | |
| Echosens North America, INC. | $11.33 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sloan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.